Cite
HARVARD Citation
Seymour, Z. et al. (2018). Quality of life is not compromised with intensification of androgen therapy in recurrent prostate cancer. Lancet oncology. 19 (10), pp. 1275-1276. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Seymour, Z. et al. (2018). Quality of life is not compromised with intensification of androgen therapy in recurrent prostate cancer. Lancet oncology. 19 (10), pp. 1275-1276. [Online].